← Back to Search

Prehabilitation for Esophageal Cancer

N/A
Waitlist Available
Led By Enrico M Minnella, MD PhD
Research Sponsored by McGill University Health Centre/Research Institute of the McGill University Health Centre
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patients with non-metastatic esophageal cancer undergoing neo-adjuvant chemotherapy and surgery.
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from baseline to post neo-adjuvant therapy (average duration 6-8 weeks)
Awards & highlights

Study Summary

This trial will test if prehabilitation, which is preparing for surgery beforehand, can help people with esophageal cancer.

Eligible Conditions
  • Esophageal Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from baseline to post neo-adjuvant therapy (average duration 6-8 weeks)
This trial's timeline: 3 weeks for screening, Varies for treatment, and change from baseline to post neo-adjuvant therapy (average duration 6-8 weeks) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Oxygen consumption (VO2)

Trial Design

2Treatment groups
Experimental Treatment
Group I: Supervised PrehabilitationExperimental Treatment1 Intervention
Prehabilitation will include exercise, nutrition, and anxiety-coping intervention. This group will receive a supervised, in-hospital training.
Group II: Home-based PrehabilitationExperimental Treatment1 Intervention
Prehabilitation will include exercise, nutrition, and anxiety-coping intervention. This group will receive a home-based training.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Prehabilitation
2013
Completed Phase 3
~1040

Find a Location

Who is running the clinical trial?

McGill University Health Centre/Research Institute of the McGill University Health CentreLead Sponsor
442 Previous Clinical Trials
159,120 Total Patients Enrolled
Enrico M Minnella, MD PhDPrincipal InvestigatorMcGill University

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~10 spots leftby Apr 2025